A new three-part study showed that a delayed-release, extended-release form of methylphenidate could be given to adults in the evening with or without food and would not exert any clinically meaningful effect for at least ...
Apr 2, 2019
0
0
Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric diagnoses among children and adolescents worldwide. The standard of care for ADHD typically includes long-term treatment with stimulants, ...
Mar 27, 2019
0
4
Choline, an essential B vitamin nutrient, can prevent fetal brain developmental problems that often occur after prenatal maternal infections such as colds and influenza (flu).
Mar 14, 2019
0
3
Learning difficulties in schoolchildren are not always associated with visual problems, since they may be neurobiological or derived from other alterations such as dyslexia or attention deficit hyperactivity disorder (ADHD). ...
Mar 14, 2019
0
0
Young adults at risk of developing problems with addiction show key differences in an important region of the brain, according to an international team led by researchers at the University of Cambridge.
Mar 4, 2019
0
32
The higher the cotinine levels were in the mother's blood during pregnancy, the greater was the child's risk of developing attention deficit hyperactivity disorder (ADHD) later in life, showed an epidemiological study conducted ...
Feb 26, 2019
0
10
A new short-term pilot study in children and teens 6-17 years old with attention-deficit hyperactivity disorder (ADHD) has shown saffron to be as effective at controlling symptoms as methylphenidate, the commonly prescribed ...
Feb 21, 2019
0
8
(HealthDay)—Young children with autism are more than twice as likely to have sleep problems than typical kids or those with other developmental delays, a new study reports.
Feb 11, 2019
0
2
Many children with attention deficit hyperactivity disorder (ADHD) are missing out on assessment and treatment according to new research by the Murdoch Children's Research Institute.
Feb 6, 2019
0
0
A new study in children aged 6 to 12 years of dasotraline, a promising new treatment for attention deficit hyperactivity disorder (ADHD), showed significant improvement in efficacy in the treatment of ADHD compared to placebo ...
Feb 4, 2019
0
1
